ExaWizards Inc. (4259) AI Stock Analysis

• Market Cap: ¥54.51B
• Dividend Yield: N/A
• Average Volume (3M): 1.54M
• Price to Earnings (P/E): 43.6
• Beta (1Y): 1.13
• Revenue Growth: 8.98%
• EPS Growth: -581.59%
• Country: JP
• Employees: 548
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 3.65
• Shares Outstanding: 87,084,500
• 10 Day Avg. Volume: 1,998,980
• 30 Day Avg. Volume: 1,537,346
• PEG Ratio: -0.03
• Price to Book (P/B): 10.12
• Price to Sales (P/S): 2.54
• P/FCF Ratio: 49.30
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 10.75
• Revenue Forecast (FY): ¥11.54B

• Rating: 53 Neutral
• Price Target: ¥633.00 ▼(-0.63% Downside)
• Action: Reiterated Date: 03/06/26
• Date: Action: Reiterated 03/06/26

The score is primarily supported by strong revenue growth and improving cash flow (positive free cash flow in 2025). It is held back by ongoing profitability challenges, clear technical weakness (below major moving averages with negative MACD), and a high P/E valuation.

Positive Factors

Revenue Growth

A 17% revenue increase indicates durable demand for ExaWizards' AI/DX services, supporting scale and deeper client relationships. Sustained top-line growth provides runway to invest in product development and sales capabilities, improving odds of converting projects into longer-term contracts and expanding market share over months.

Cash Generation

Transitioning to positive free cash flow is a structural improvement that enhances financial flexibility. Positive FCF reduces reliance on external financing, enables reinvestment in product and commercial expansion, and provides a buffer for cyclicality in project demand, strengthening the firm's ability to fund growth sustainably.

High Gross Margin

A ~58% gross margin signals favorable unit economics typical of software and specialist consulting, offering room to absorb SG&A while moving toward profitability. If operating leverage improves, high gross margins can translate into durable operating profits and stronger cash conversion as scale increases over the medium term.

Negative Factors

Profitability Challenges

Persistent negative EBIT and EBITDA indicate core operating losses despite revenue growth, implying structural cost or operating inefficiencies. Continued unprofitability limits retained earnings, increases dependence on external capital, and may constrain long-term investment in product R&D or sales needed to capture larger market share.

Moderate Leverage & Shrinking Equity

A debt-to-equity around 1.0 combined with falling equity and assets reduces financial flexibility and raises refinancing risk. This capital-structure pressure can limit strategic choices, increase interest burdens, and make the firm more vulnerable to revenue shocks, impeding sustained investment in scaling AI offerings.

Project-heavy Revenue Mix

Reliance on project-based engagements makes revenue lumpy and harder to predict, contributing to historical cash-flow volatility. Without a clear, durable shift to recurring contracts, the company faces challenges in smoothing revenues and margins, which undermines long-term predictability and the ability to plan multi-period investments.

ExaWizards Inc. Business Overview & Revenue Model

Company Description

ExaWizards Inc. develops AI-enabled services for industrial innovation and social problems solutions in Japan. It operates through AI Platform and AI Products segments. The company provides AI platform services; and services for AI understanding, planning, design, development, operation, and usage. It also develops and offers AI products to solve generic industrial and social issues. The company was incorporated in 2016 and is headquartered in Tokyo, Japan.

How the Company Makes Money

ExaWizards Inc. generates revenue through multiple streams, primarily by offering subscription-based software services and licensing their proprietary AI technologies to businesses across various industries. The company also engages in consulting services, helping organizations implement AI solutions tailored to their specific needs. Significant partnerships with healthcare providers and financial institutions further bolster their revenue, as these collaborations often lead to customized projects and long-term contracts. Additionally, ExaWizards may earn income through performance-based fees tied to the success of their AI implementations, contributing to a diversified and resilient revenue model.

ExaWizards Inc. Financial Statement Overview

Summary

Strong revenue growth (+17% from 2024 to 2025) and improving cash generation with free cash flow turning positive in 2025 support the score. Offsetting this, profitability remains weak with negative net profit/EBIT margins and negative EBITDA, while the balance sheet shows moderate leverage (debt-to-equity ~1.04) alongside declining equity and total assets.

Income Statement

ExaWizards Inc. has shown significant revenue growth with a 17% increase from 2024 to 2025. However, the company is struggling with profitability as indicated by negative net profit margins and EBIT margins. Gross profit margin remains healthy at approximately 57.8%, but negative EBITDA indicates operational challenges.

Balance Sheet

The balance sheet reflects moderate financial stability with a debt-to-equity ratio of 1.04 in 2025, which suggests balanced leverage. However, the declining stockholders' equity and reduction in total assets over the years pose potential risks. The equity ratio of around 35% in 2025 indicates a moderate reliance on equity financing.

Cash Flow

Cash flow analysis shows a positive trend with free cash flow turning positive in 2025, indicating improved cash management. The operating cash flow to net income ratio is favorable, demonstrating effective conversion of income to cash. However, historical volatility in cash flows suggests potential risks in sustaining this trend.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	10.15B	9.81B	8.38B	5.59B	4.81B	2.61B
Gross Profit	6.25B	5.67B	4.69B	3.14B	3.05B	1.66B
EBITDA	-1.42B	-1.75B	67.00M	359.00M	90.00M	-441.13M
Net Income	-2.21B	-2.58B	-610.00M	-141.00M	-137.00M	-592.69M
Balance Sheet
Total Assets	7.46B	7.11B	10.13B	7.96B	7.89B	3.69B
Cash, Cash Equivalents and Short-Term Investments	3.85B	3.01B	3.49B	5.23B	5.54B	2.34B
Total Debt	2.48B	2.55B	2.85B	310.00M	345.22M	815.00M
Total Liabilities	4.35B	4.57B	5.14B	1.34B	1.26B	1.30B
Stockholders Equity	3.02B	2.46B	4.93B	6.54B	6.59B	2.38B
Cash Flow
Free Cash Flow	0.00	505.00M	-1.12B	-843.00M	-445.00M	-1.09B
Operating Cash Flow	0.00	621.00M	-197.00M	71.00M	24.00M	-528.13M
Investing Cash Flow	0.00	-880.00M	-2.95B	-483.00M	-701.00M	-572.57M
Financing Cash Flow	0.00	-221.00M	1.41B	105.00M	3.88B	1.80B

ExaWizards Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 637.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4259, the sentiment is Negative. The current price of 637 is below the 20-day moving average (MA) of 661.50, below the 50-day MA of 694.88, and above the 200-day MA of 586.74, indicating a neutral trend. The MACD of -17.49 indicates Positive momentum. The RSI at 42.94 is Neutral, neither overbought nor oversold. The STOCH value of 39.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4259.

ExaWizards Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
5586	65 Neutral	¥12.69B	37.90	―	―	25.41%	9.69%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
5572	59 Neutral	¥8.90B	33.78	―	―	60.41%	-27.67%
4476	56 Neutral	¥3.89B	35.15	―	―	10.43%	-65.78%
4259	53 Neutral	¥54.51B	43.64	―	―	8.98%	-581.59%
4382	52 Neutral	¥12.50B	-90.49	―	―	16.29%	93.98%
4425	44 Neutral	¥22.60B	35.20	―	―	36.08%	-7.71%

ExaWizards Inc. Corporate Events

ExaWizards Launches AI-Native Systems Integration Subsidiary Exa Frontier Edge

ExaWizards Inc. has approved the creation of a wholly owned subsidiary, Exa Frontier Edge Inc., to develop and operate systems built from the ground up around AI agents and AI-driven development. The new company, capitalized at 300 million yen and based in Tokyo, is intended to free operations from legacy constraints and pioneer a next-generation, AI-native systems integration model that could reshape how software and IT services are delivered.

By establishing Exa Frontier Edge, ExaWizards aims to get ahead of the disruptive shift caused by generative AI and AI agents that are rapidly transforming software lifecycles and business operations. The move is positioned as a strategic break from conventional systems integration, with the expected financial impact already incorporated into ExaWizards’ upwardly revised earnings forecast for the fiscal year ending March 31, 2026.

The most recent analyst rating on (JP:4259) stock is a Hold with a Yen644.00 price target. To see the full list of analyst forecasts on ExaWizards Inc. stock, see the JP:4259 Stock Forecast page.

ExaWizards Lifts Full-Year Earnings Outlook on Surging AI Product Demand

ExaWizards Inc. has raised its full-year consolidated earnings forecast for the fiscal year ending March 2026, citing stronger-than-expected performance in its AI Products Business. The company now projects total sales of ¥11.9 billion and operating profit of ¥1.5 billion, representing modest revenue growth but a double-digit percentage increase in expected operating income.

Management said AI product growth significantly outpaced initial assumptions in the first half, while structural reforms in the AI Solution Services Business have built a more profitable, scalable model. Despite stepping up hiring, next-generation product development, and marketing in the second half, lower-than-expected corporate action costs and stronger AI demand are set to lift both revenue and operating profit above prior guidance.

The most recent analyst rating on (JP:4259) stock is a Hold with a Yen644.00 price target. To see the full list of analyst forecasts on ExaWizards Inc. stock, see the JP:4259 Stock Forecast page.

ExaWizards Transfers HR Tech Business to AI Subsidiary to Sharpen AX Focus

ExaWizards Inc. has approved a simplified absorption-type company split to transfer its HR Tech business, built around the exaBase DX Assessment & Learning talent development service and newer AX-focused programs, to its wholly owned subsidiary Exa Enterprise AI Inc. The move responds to a shift in market demand from digital transformation to AI transformation, as clients seek more advanced AI utilization and talent development solutions.

By consolidating overlapping customer bases and service offerings into Exa Enterprise AI, the group expects faster decision-making, higher development speed, and stronger synergies across planning, development, and sales. The restructuring, effective April 1, 2026, leaves share capital and stock acquisition rights at the parent unchanged and is intended to optimize resource allocation and support sustainable growth in AI-driven HR solutions and enterprise productivity tools.

The most recent analyst rating on (JP:4259) stock is a Buy with a Yen1020.00 price target. To see the full list of analyst forecasts on ExaWizards Inc. stock, see the JP:4259 Stock Forecast page.

ExaWizards Unveils Q3 FY2026/3 Financial Results and Business Progress

ExaWizards Inc. released its financial results presentation for the third quarter of the fiscal year ending March 2026. The materials outline consolidated financial performance, segment progress, and business updates, indicating a structured disclosure of how each business area is advancing and how the company is tracking against its strategic and operational objectives.

The document highlights an executive summary of Q3, detailed consolidated results, and an overview of business segment developments. It also points to ongoing business updates and appendices that frame the company’s current performance trajectory, providing stakeholders with a snapshot of operational progress and the state of its AI-focused business portfolio.

The most recent analyst rating on (JP:4259) stock is a Buy with a Yen1020.00 price target. To see the full list of analyst forecasts on ExaWizards Inc. stock, see the JP:4259 Stock Forecast page.

ExaWizards Swings to Profit and Lifts Outlook on Strong Nine-Month Results

ExaWizards Inc. reported consolidated net sales of ¥8.35 billion for the nine months ended December 31, 2025, up 17.1% year on year, and moved into profitability with operating profit of ¥1.03 billion and profit attributable to owners of parent of ¥695 million, reversing a loss in the prior-year period. The company also strengthened its financial position, with total assets rising to ¥8.34 billion and the equity ratio improving to 44.0%, while maintaining a no-dividend policy for the fiscal year.

The company revised its full-year forecast, now expecting net sales of ¥11.8 billion, a 20.3% increase from the previous year, and operating profit of ¥1.35 billion, signaling confidence in sustained growth and margin improvement. These results and forecasts suggest a successful scaling of its AI-related services business, enhanced capital structure, and improving shareholder value prospects despite the continued decision not to return cash via dividends at this stage.

The most recent analyst rating on (JP:4259) stock is a Buy with a Yen1020.00 price target. To see the full list of analyst forecasts on ExaWizards Inc. stock, see the JP:4259 Stock Forecast page.

ExaWizards Subsidiary Files Clinical Trial Plan for Priority-Reviewed AI Cognitive Diagnostic Tool

ExaWizards’ wholly owned subsidiary ExaMD Inc. has submitted a clinical trial notification to Japan’s Pharmaceuticals and Medical Devices Agency for its AI-powered cognitive function diagnostic support software, a Software as a Medical Device designated by the health ministry for priority review. The trial, targeting up to 100 participants over three months, will assess the tool’s ability to classify individuals as cognitively normal or suspected of cognitive decline using about one minute of free conversation, comparing estimated MMSE scores to measured results while monitoring safety, and the company has already factored the associated costs into its current fiscal year investment plans, indicating no change to its full-year earnings forecast at this stage.

The most recent analyst rating on (JP:4259) stock is a Hold with a Yen840.00 price target. To see the full list of analyst forecasts on ExaWizards Inc. stock, see the JP:4259 Stock Forecast page.